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Summary
Introduction: Chondrosarcoma (CS) is a primary malignant bone tumor with cartilaginous dif-
ferentiation. The only available treatment is carcinological surgical resection since the usual
adjuvant treatments are ineffective. The pelvic location creates speciﬁc technical difﬁculties
both for exeresis and reconstruction. Our objective was to evaluate the carcinological and
functional outcomes of inter-ilioabdominal amputation and conservative surgery.
Materials and methods: We retrospectively studied 59 cases of pelvis chondrosarcoma managed
in our department between 1968 and 2003. Demographic, anatomopathological, surgical and
survival data were analyzed. Survival was estimated by the Kaplan-Meier curves and the cumu-
lative incidence method. Multivariate analysis was used to identify all possible independent
prognostic variables.
Results: There were 33 men and 26 women, with an average age of 48 years. The average
follow-up duration was 94 months. Eleven patients had a grade 1 chondrosarcoma, 36 a grade 2
chondrosarcoma, ﬁve were grade 3, and seven were dedifferentiated chondrosarcoma. Eleven
patients underwent an inter-ilioabdominal disarticulation, and 48 had a more conservative
surgery. Resection margins proved healthy in 46 patients (78%). Eighteen patients (31%) had
a local recurrence, and 12 (20%) had metastases. At last follow-up, 30 patients (51%) were
still alive without any sign of recurrence. Twenty-three patients (39%) died from the disease.
Multivariate analysis showed that margin invasion was associated with a deﬁnitely increased
local recurrence rate. A high tumoral grade was correlated with a greater risk of metastases
occurrence. These two last factors (margin status and tumor grade) as well as acetabulum
involvement were correlated with a reduced survival rate.
Function was better among patients treated by conservative surgery, and among them, even
better when the peri-acetabular area remained intact.
Our study conﬁrmed that resection margins quality is a major prognostic factor both for local
control and for survival. On the other hand, local recurrence is an adverse survival prognosis
factor and is itself correlated with resection margins quality.
∗ Corresponding author.
E-mail address: xavier.deloin@cch.aphp.fr (X. Deloin).
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healthy margins guarantee, or when local conditions make it impossible to hope for a good
quality reconstruction.
Level of Evidence.— Level IV; therapeutic retrospective study.
© 2009 Elsevier Masson SAS. All rights reserved.
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Grade 2 CSs were most frequent (n = 36). This series had
seven dedifferentiated CS.ntroduction
hondrosarcoma (CS) is a malignant skeletal tumor with
artilaginous differentiation. In terms of incidence, it repre-
ents the second most frequent bone tumor in adults [1], and
s preferentially located in the pelvis in 22 to 39% of cases
2—7]. CSs of the pelvic girdle remain asymptomatic in the
ong-term and may thus be large at the time of diagnosis.
From a therapeutic viewpoint, CS is individualized
rom other primary skeletal tumors as it is radioresistant
nd chemoresistant: its only treatment is carcinological
urgical exeresis. However, depth in the pelvis, tumor
ize and its connections with local articular, nervous,
ascular and visceral structures very often make carcinolog-
cal exeresis difﬁcult and require complex reconstructions
8—12].
The objective of this work is to evaluate the carcinolog-
cal and functional results of different surgical treatments
f CS of the pelvic girdle.
aterials and methods
e report data from a retrospective, monocentric study in
series of 59 patients with CS of the pelvis and treated
urgically by the Orthopaedics Service of Cochin Hospital
etween 1968 and 2003. Patients treated initially in another
stablishment were not included.
In all cases, the diagnosis of CS was conﬁrmed histolog-
cally by a referred pathologist specialized in the diagnosis
f tumors of the locomotor apparatus. The following clin-
cal data were analyzed: sex, age, initial clinical picture,
uration of symptoms at the time of diagnosis. Tumor loca-
ion was studied on radiographs as well as by scanner and
agnetic resonance imaging when they were available. The
opographical characteristics of the tumor were expressed
ccording to the Muskuloskeletal Tumor Society classiﬁca-
ion [10,13]. Macroscopic data, i.e., tumor size deﬁned by
ts largest diameter, and microscopic ﬁndings, i.e. grade
ccording to O’Neal and Ackerman [14], were collected.
esection margins were analyzed according to the classiﬁ-
ation of Enneking et al. [15]. Type of surgical intervention,
ocal recurrence, metastases, and patient outcome were
T
F
itudied. Function was evaluated by walking, and pain graded
ccording to the 30-point score of the Musculoskeletal Tumor
ociety [16].
Follow-up was calculated from the intervention data at
ochin Hospital until the day of death or the last follow-
p. Survival was estimated by Kaplan-Meier curves and the
umulated incidence method in the presence of events com-
eting with the event of interest.
Cox’s proportional model was used to estimate the effect
hazard ratio or relationship of instant risks) of different
ariables on the events considered. Multivariate analysis
erved to identify a set of variables independently prognos-
ic of the events. The analyses were performed with the R
.5.1 statistical analysis program; all tests were bilateral
nd signiﬁcant from a threshold of 0.05.
esults
pidemiology
hirty-three men and 26 women, with an average age of 48
ears at the time of diagnosis (23 to 78 years) were managed
or CS of the pelvic girdle. Average follow-up was 94 months
3—311 months). The patients were followed for a minimum
f four years or until their death.
istology
ifty-two patients had a biopsy before exeresis. In seven
ases, the histological diagnosis was conﬁrmed by the study
f exeresis pieces without preliminary biopsy.
Forty-seven patients (80%) had a primary CS, and 12
20%) had a secondary CS with a preexistent benign tumor
Table 1).394 X. Deloin et al.
Peri-acetabular chondrosarcoma location (in zone 2) appears to be a poor oncological prog-
nosis factor since, in this location, obtaining healthy margins appears particularly difﬁcult.
Compared to resection, inter-ilioabdominal amputation did not prove its superiority concern-
ing resection margins quality or survival. However, resection guaranteed a better functional
outcome.
Conclusion.— Chondrosarcoma of the pelvic girdle remains of worse prognosis than periph-
eral bones chondrosarcoma since the critical prognosis factor is the resection margins quality.
This location, and especially the peri-acetabular zone, poses difﬁcult speciﬁc technical prob-
lems when conservative surgery is selected. Various imaging techniques should help better
envision tumor resection extent. Inter-ilioabdominal amputation should only be resorted to
in non-metastatic patients, when the tumor does not seem to be removable with sufﬁcientopography
ourteen patients (24%) had a zone 1 (iliac) tumor, includ-
ng four with sacral invasion; 42 patients (71%) had a zone
Pelvic chondrosarcomas: Surgical treatment options 395
Table 1 Epidemiological and histological characteristics of
our series.
n (%)
Men 33 (56)
Women 26 (44)
Tumor grade [20]
1 11 (19)
2 36 (61)
3 5 (8)
Dedifferentiated 7 (12)
Tumor size
≤ 10 cm 35 (59)
> 10 cm 24 (41)
Primary tumors 47 (80)
Secondary tumors 12 (20)
Solitary exostosis 2
Exostosis disease 7
Zone 3CS (n=3)
All cases were treated by exeresis of all or part of the
ischium and the pubis.
Resection margins
They were considered to be healthy in 46 cases (78%),
marginal in two cases (3%) and contaminated in 11 cases
(19%).
In the amputation group (n = 11), the margins were
healthy in seven cases (63%), and contaminated in four cases
(37%).
In the conservative treatment group (n = 48), the margins
were healthy 39 times (81%), exeresis was marginal twice
(5%), and the margins were contaminated seven times (14%).
Reconstruction
After resection of the iliac wing (n = 13), reconstruction was
carried out in three cases, by autografts (n = 2) or allografts
(n = 1).
After resection of all or part of the acetabulum (n = 32),
reconstruction was conducted according to the following
techniques:
• total hip prostheses, n = 10,with six Puget interventions
(Fig. 1);
• saddle prostheses, n = 8;
• arthrodesis, n = 7, with three femoro-iliac arthrodesis,
three femoro-obturator arthrodesis and one femorocoty-
loid arthrodesis;
• bone reconstructions of the cotyle, n = 4;
• neocotyles at the expense of the iliac wing, n = 2.
In one case, no reconstruction was undertaken: resection
involved a non-weight-bearing zone of the posterior cotyle
wall.
No reconstructions were carried out after isolated resec-
tion of the pubis (n = 3).Multiple
Ollier’s disease 2
Paget’s disease 1
2 (acetabular) lesion, and three patients (5%) had zone 3
(ischiopubic) lesion.
Clinical data
The average duration of symptoms before the diagnosis was
14.5 months. Pain was the most frequent symptom (n = 45).
Eight patients consulted because of palpable tumefaction.
The other patients consulted because of abnormal radiolog-
ical imaging.
One patient had a pulmonary metastasis at the time of
diagnosis.
Treatment
Eleven inter-ilioabdominal disarticulations and 48 conser-
vative interventions were performed. In three cases of
dedifferentiated CS, chemotherapy was associated with
surgery.
Zone 1 CS (n=14)
Eleven patients underwent partial or total resection of the
ilium. In two cases, exeresis included the sacrum. An ampu-
tation was undertaken because of major invasion of the
sacral plexus.
Zone 2 CS (n=42)
There were ﬁve isolated resections of the acetabulum.
Twenty patients had partial or total resection of the
acetabulum associated with partial or total resection of the
pubis or ischium.Four partial or total resections of the acetabulum were
undertaken in association with all or part of the ilium.
Three patients had resection of the acetabulum, ilium
and ischium and/or the pubis.
Ten inter-ilioabdominal disarticulations were performed. Figure 1 Reconstruction according to the Puget technique.
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Carcinological results
Survival
Thirty patients (51%) were alive without signs of recurrence
at last follow-up, with a survival average of 123 months (48
to 272 months).
Twenty-three patients (39%) died from the disease. Their
average survival was 69 months (3 to 312 months).
Six patients (10%) died from another cause without known
recurrence at the time of their death, within an average of
59 months (6 to 119 months).
Thus, the global survival rate was 90% (CI: 82—98%) at
one year, 66% (CI: 55—80%) at ﬁve years, 52% (CI: 39—70%)
at 10 years and 45% (CI: 32—64%) at 15 years (Fig. 2).
Multivariate analysis searched for risk factors of death.
This analysis showed that invasive resection margins
(p = 0.00001, RR = 7.28) (Fig. 3), high histological grade (3 or
dedifferentiated) (p = 0.0005, RR = 4.57) (Fig. 4), and tumors
invading the acetabulum (p = 0.049, RR = 3.24) were statisti-
cally pejorative factors for survival.
Local recurrence
Eighteen patients (31%) had a local recurrence within an
average period of 37 months (5 to 230 months), associated
in four cases (22%) with one or more metastases at the time
of diagnosis (Table 2).
Among the 14 patients with a local recurrence without
metastasis at the time of diagnosis, three (21%) had sec-
ondary metastases within an average of 27 months after the
ﬁrst recurrence (15 to 43 months).
Local recurrence was treated surgically in 12 cases: inter-
ilioabdominal disarticulation from diagnosis in one case,
intralesional exeresis surgery in 11 cases, multiple surgeries
in six cases (two to 11 revisions). Three patients had an inter-
ilioabdominal amputation afterwards. A patient with local
recurrence and synchronous adrenal metastasis received
chemotherapy (dedifferentiated CS).
Figure 2 Kaplan-Meier analysis of global patient survival. The
studied event was patient death in relation to the disease.
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Cigure 3 Comparison according to the Cox model of global
atient survival as a function of resection margin quality.
A patient with local recurrence and synchronous pul-
onary metastasis was treated by chemotherapy alone.
Five patients received no treatment.
All patients who had a local recurrence died within an
verage time period of 38 months (0—240 months) after the
iagnosis of recurrence. Reoperated patients lived an aver-
ge of 55 months (1—240 months), non-reoperated patients
ived an average of 3.5 months (0—6 months), but among
hem, three had metastases at the time of local recurrence
iagnosis.
igure 4 Comparison according to the Cox model of global
atient survival as a function of histological tumor grade. Low
rade: grades 1 and 2; high grade: grade 3 and dedifferentiated
S.
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Table 2 Characteristics of local recurrences.
Local recurrences
Cases/total 18 (31%)
Location
Zone 1 3/14 (21%)
Zone 2 14/42 (33%)
Zone 3 1/3 (33%)
Margins
Healthy 8/46 (17%)
Marginal 2/2 (100%)
Contaminated 8/11 (72%)
Initial CS grade
1 2/11 (18%)
2 12/36 (33%)
Dedifferentiated 4/7 (57%)
Time period after initial intervention 37 months
Associated metastases
Synchronous 4
Asynchronous 3
Treatment
Surgery 12 (66%)
Chemotherapy 2 (11%)
Table 3 Characteristics of metastases.
Metastases
Cases/total 12
Postoperative occurrence 41 months
Without local recurrence 5/12 (42%)
With local recurrence 7/12 (58%)
Location
Lungs 11
Liver 2
Adrenals 1
Initial CS grade
2 7/36 (19%)
3 1/5 (20%)
Dedifferentiated 4/7 (57%)
CS topography
Zone 2 11
i
(
M
T
w
fNone 5 (28%)
Delayed diagnosis — death 38 months
Multivariate analysis objectively established that the risk
of local recurrence was strongly correlated with invasion of
the resection margins (p = 0.001). The probability of local
recurrence at 10 years was 15% for patients with healthy
resection margins, and was 54% for patients whose margins
were contaminated (Fig. 5).
1
t
t
e
Figure 5 Analysis according to the cumulative incidence method
function of resection margin quality. a: event probability local recurZone 3 1
Delayed diagnosis — death 8 months
On the other hand, high histological grade (3 and ded-
fferentiated) was not a risk factor for local recurrence
p = 0.3), just like tumor location (p = 0.28) (Fig. 6).
etastases
welve patients (20%) developed metastases, associated
ith local recurrence in seven cases (58%), synchronous in
our, or secondary in three (Table 3).
The average time of occurrence was 41 months (3 to
89 months). Metastases were most frequently localized in
he lungs (n = 11), associated in two cases with liver metas-
ases. We observed a case of adrenal metastasis during the
volution of dedifferentiated CS.
of local recurrence risk (Fig. 5a) and metastasis (Fig. 5b) as a
rence metastases.
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F thod of local recurrence risk (Fig. 6a) and metastasis (Fig. 6b) as a
f ; high grade: grade 3 and dedifferentiated CS.
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Table 4 Postoperative complications.
Amputation
(n = 11)
Conservative
treatment (n = 48)
Perioperative
Hemorrhagic 1 1
Sciatic paralysis 0 2
Visceral wounds 2 1
Infectious
Superﬁcial 5 6
Deep 2 4
Mechanical
p
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figure 6 Analysis according to the cumulative incidence me
unction of histological tumor grade. Low grade: grades 1 and 2
Metastases complicated the evolution of seven grade 2
S (19% of grade 2 CS), one grade 3 CS (20%) and four ded-
fferentiated CS (57%).
Two metastasectomies were performed: one pulmonary
etastasis and one adrenal metastasis, responsible for per-
perative patient death.
All patients died within an average time period of eight
onths (1 to 55 months) after the diagnosis of metastasis.
Multivariate analysis showed that high histological grade
3 or dedifferentiated) was correlated with a high risk of
etastasis (p = 0.03) (Fig. 6). Tumor size and resection mar-
in quality were not statistically signiﬁcantly correlated with
he occurrence of metastasis.
unctional results
he average score obtained was 18 out of 30 (5 to 28).
In amputated patients (n = 3), it was on average six
oints. These patients received Canadian prostheses, and
ne of them used it only inside his residence.
In patients treated by conservative surgery, the average
core was 20 (14 to 28). Patients whose resection did not
ouch the acetabulum scored an average of 26 points (20 to
8), whereas those whose resection involved all or part of
he cotyle had an average score of 16 points (14 to 21).
omplications
orty complications occurred and are regrouped in Table 4.
The main complications were infectious in the ampu-
ation group, and mechanical in the conservative surgery
roup.
In addition, three perioperative deaths occurred after
urgical revision for recurrences: a patient died during
xeresis of an adrenal metastasis 22 months after his ini-
ial conservative treatment for dedifferentiated CS. Another
p
i
o
9Dislocations 0 6
Other 0 10
atient died in the course of his ﬁfth palliative revision
intralesional tumorectomy), 122 months after his initial
ntervention for a grade 2 CS. Finally, a patient died on
ay 10 of palliative surgical revision for massive recurrence,
even months after inter-ilioabdominal disarticulation for a
assive grade 2 myxoid CS.
iscussion
pidemiology
s observed, CSs are slightly male-predominant tumors,
hich affect mature adults with peak frequency in the
ourth decade [2,3,5,7,17—20]. High-grade CS appears to be
redominant in men after 50 years [21], which we also noted
n our series.
In our series, 20% of CSs of the pelvic girdle occurred
n a benign bone tumor, with an incidence varying between
and 32%, and was comparable to that found at the level
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of the limbs [6,17,20—29]. Whereas there was no prognostic
difference between primary and secondary CSs in our series,
Sheth et al. [24] reported a better prognosis for secondary
CS.
Treatment
The only treatment of CS, whatever its location, is surgical
carcinological exeresis [3,5,6,17—19,23,24,30—40]. The sur-
vival of patients with CS of the pelvic girdle varies between
51% and 88% at 10 years [6,31,33,35,41]. It is lower than that
of patients with peripheral CS (57% to 83%) [6,37,42,43].
Block resection with healthy surgical margins makes
it possible to obtain the lowest rate of recurrence and
better survival [6,24,31,33,35,39]. The rate of healthy mar-
gins is very variable in the literature, ranging from 25 to
82% [5,24,31,33,35]. The wide variability of these data
is probably related to series inhomogeneity and operator
experience as well as the practical difﬁculty of histologi-
cally characterizing resection margins. Intralesional surgery
is a statistically signiﬁcant risk factor for local recurrence
[6,24,31,33,34,39,40].
The two series in the literature assigned to intralesional
surgery of pelvic CS both concluded that this technique is
ineffective [34,40]. This is also true for grade 1 CS for which
it was originally proposed [40] and which concurs with our
observations. Twelve out of 13 patients (92%) with inade-
quate margins had recurrences, and the sole patient who did
not have recurrence died precociously (6 months) after his
surgery, from causes unrelated to his disease (cerebrovas-
cular accident).
Tumor location was also a signiﬁcant prognostic factor.
Periacetabular location in our study was a statistically
signiﬁcant risk factor pejorative for survival. This was also
the case for Mochizuki et al. [41]. For Sheth et al. [24], zone
3 CS is a poor prognostic factor for survival, and for Ozaki et
al. [6], zone 3 location carries a greater risk of local recur-
rence, without the difference being statistically signiﬁcant.
This is probably due to the surgical difﬁculty in obtaining
healthy margins in particular locations, unlike zone 1, which
is easily accessible, with the exception of cases of crossing
the sacroiliac articulation.
Taking these data into consideration, resection margin
quality seems to be a major prognostic factor as much for
the local control of CS as for patient survival.
Relapses
In this pelvic location, local recurrences are frequent: their
incidence varies from 18 to 45% in the literature, and 31% in
our experience [6,17,21,24,31,33,35,42,43].
We have observed that the risk of local recurrence
is directly related to the quality of initially exere-
sis margins, which is corroborated by several studies
[3,6,17,21,24,31,33,35,42,43].
In our work, local recurrence constituted a poor prog-
nostic factor as it was statistically signiﬁcantly associated
with decreased survival, as demonstrated by other authors
[5,31,33,35]. According to Fiorenza et al. [43], local recur-
rence affects survival in a pejorative manner when it is
associated with one or more synchronous metastases. Only
A
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wo studies have not provided evidence of the inﬂuence of
ocal recurrence on survival [6,24].
According to Pring et al. [35], high-grade CSs are signif-
cant risk factors for local recurrence. Our study does not
onﬁrm these results.
Concerning treatment of local recurrence, we observed
hat patients undergoing surgical exeresis showed better
urvival than those who were not so treated, but the two
tudy populations were too small in size to provide proof of
statistically signiﬁcant difference.
nﬂuence of surgical technique (amputation versus
onservative treatment) on resection margin
uality
ur series did not ﬁnd evidence of a statistically sig-
iﬁcant difference between the two types of surgery to
btain healthy margins (63% for the amputation group ver-
us 81% for the conservative surgery group) or in terms
f survival. Many series arrived at the same conclusion
7,24,35,36,44,45]. Although these studies, as in our own
xperience, conﬁrm the inﬂuence of surgical margins on
ocal recurrence, none of them demonstrated the supe-
iority of a technique in achieving healthy margins and
oncluded that conservative treatment as soon as possible
hould be preferred, to guarantee better functional results
or a similar survival rate.
Two studies have reported the superiority of amputa-
ion over conservative surgery. In 1972, Marcove et al. [26]
bserved a statistically signiﬁcant difference between inter-
lioabdominal disarticulation and local resection for survival
riteria. In 2005, Donati et al. [33] showed, in a series of
25 pelvic CSs, that radical surgery made it possible to
btain a higher level of healthy surgical margins (80% versus
1% for conservative surgery, p = 0.077), and a diminution
f the local recurrence level. This result is at the limit of
igniﬁcance. Moreover, these two studies have the same lim-
tations: the age of the records studied that is responsible
or insufﬁciency of preoperative radiological assessment.
t indeed appears logical that improvements in imaging
echniques provide good assessments of margin quality and
umor resection before the intervention. According to the
ame reasoning, the use of navigation may improve the qual-
ty of exeresis [46,47]. However, Fiorenza et al. [43], in a
eries of 153 axial and peripheral CSs in 2002, did not man-
ge to show that improved preoperative imaging associated
ith radical surgery made it possible to improve resection
argins, the rate of local recurrence and survival.
It thus does not appear possible to conclude on the supe-
iority of amputation both in terms of resection margin
uality and survival. Our rare indications of ﬁrst-intention
mputation to date remain bulky tumours with vascular or
erve invasion, infected tumors or on radiation zones, in
on-metastatic patients.
unctions already reported in the literature [6,35,48,49], our series
ogically conﬁrms that patients treated by conservative
urgery have a higher functional score than those treated by
mputation, and this in a sustainable manner. Indeed, among
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atients treated by ﬁrst-intention conservative surgery, 92%
reserved their limb until the last follow-up. Studies pub-
ished in the last 10 years objectively quantiﬁed the limb
reservation level at the latest follow-up after initial con-
ervative surgery, varying from 48 to 90% [6,24,33,35,41].
he large variability of these data is probably related to the
reat heterogeneity of these series.
Among the reconstructions, the functional results were
orse than those concerning the acetabular zone. Zone
reconstructions only or isolated zone 3 resections with-
ut reconstruction had a better functional prognosis. These
esults conform with those reported in the literature
13,35], acetabular reconstruction remaining the main dif-
culty of reconstructive pelvic surgery [9,11,13,48—53].
onclusion
he survival of patients with CS of the pelvis is related to
ocal recurrence, initial tumor location and grade. The risk
f local recurrence is related to resection margin quality.
The main objective of surgical treatment must thus be to
btain healthy resection margins, while preserving the limb
nd its function as much as possible.
There is no proof that inter-ilioabdominal disarticulation
s superior to conservative surgery in terms of this objec-
ive and survival. On the other hand, conservative surgery
ives better functional results than amputation without poor
urvival.
It is therefore not advisable to propose inter-
lioabdominal disarticulation when conservative surgery is
chievable. Preoperative imaging will allow us to better
ppreciate lesion resection and the possibility of obtaining
ealthy margins.
The survival of patients treated for CS of the pelvic gir-
le remains lower than those with peripheral locations as
t is more difﬁcult to obtain healthy margins. The devel-
pment of adjuvant treatments is particularly expected to
imit the consequences of incorrect margins. Margin quality
ould gain with the use of peroperative navigation systems.
onﬂicts of interest
one.
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